SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-070078
Filing Date
2024-06-06
Accepted
2024-06-06 18:59:27
Documents
2
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4912
2 EX-24 ck0002012593-ex24.htm EX-24 11453
  Complete submission text file 0000950170-24-070078.txt   17837
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Issuer) CIK: 0002012593 (see all company filings)

IRS No.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RAPPORT THERAPEUTICS 1325 BOYLSTON ST., SUITE 401 BOSTON MA 02215
Business Address
Yeleswaram Krishnaswamy (Reporting) CIK: 0002022156 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42121 | Film No.: 241026799